EP0647134A4 - METHODS AND COMPOSITIONS USED TO TREAT DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (-). - Google Patents

METHODS AND COMPOSITIONS USED TO TREAT DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (-).

Info

Publication number: EP0647134A4
Authority: EP; European Patent Office
Prior art keywords: conditions; methods; optically pure; compositions used; treat depression
Prior art date: 1992-06-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP93915448A

Other languages

German (de)

French (fr)

Other versions

EP0647134A1 (en

Inventor

James W Young

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sumitomo Pharma America Inc

Original Assignee

Sepracor Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-23

Filing date

1993-06-22

Publication date

1997-07-30

1993-06-22 Application filed by Sepracor Inc filed Critical Sepracor Inc

1995-04-12 Publication of EP0647134A1 publication Critical patent/EP0647134A1/en

1997-07-30 Publication of EP0647134A4 publication Critical patent/EP0647134A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP93915448A 1992-06-23 1993-06-22 METHODS AND COMPOSITIONS USED TO TREAT DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (-). Withdrawn EP0647134A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US90304092A	1992-06-23	1992-06-23
US903040		1992-06-23
PCT/US1993/005966 WO1994000114A1 (en)	1992-06-23	1993-06-22	Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine

Publications (2)

Publication Number	Publication Date
EP0647134A1 EP0647134A1 (en)	1995-04-12
EP0647134A4 true EP0647134A4 (en)	1997-07-30

Family

ID=25416838

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP93915448A Withdrawn EP0647134A4 (en)	1992-06-23	1993-06-22	METHODS AND COMPOSITIONS USED TO TREAT DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (-).

Country Status (5)

Country	Link
EP (1)	EP0647134A4 (en)
JP (1)	JPH08500093A (en)
AU (1)	AU4542893A (en)
CA (1)	CA2138998A1 (en)
WO (1)	WO1994000114A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020006963A1 (en) *	1992-06-23	2002-01-17	Young James W.	Method of using and compositions comprising (-) sibutramine optionally in combination with other pharmacologically active compounds
GB9402641D0 (en) *	1994-02-11	1994-04-06	Boots Co Plc	Therapeutic agents
US5676967A (en) *	1995-04-18	1997-10-14	Brennen Medical, Inc.	Mesh matrix wound dressing
DE19518988A1 (en) *	1995-05-29	1996-12-05	Basf Ag	Use of aryl substituted cyclobutylalkylamines to treat obesity
GB9619962D0 (en) *	1996-09-25	1996-11-13	Knoll Ag	Medical treatment
US6331571B1 (en)	1998-08-24	2001-12-18	Sepracor, Inc.	Methods of treating and preventing attention deficit disorders
US6974838B2 (en)	1998-08-24	2005-12-13	Sepracor Inc.	Methods of treating or preventing pain using sibutramine metabolites
US6339106B1 (en)	1999-08-11	2002-01-15	Sepracor, Inc.	Methods and compositions for the treatment and prevention of sexual dysfunction
US6476078B2 (en)	1999-08-11	2002-11-05	Sepracor, Inc.	Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6046242A (en) *	1998-11-27	2000-04-04	Basf Aktiengesellschaft	Use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
US6197828B1 (en)	1998-12-01	2001-03-06	Sepracor, Inc.	Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6342533B1 (en)	1998-12-01	2002-01-29	Sepracor, Inc.	Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6696495B2 (en)	1998-12-02	2004-02-24	Snowden Pharmaceuticals, Llc	Treatment of disorders secondary to organic impairments
US6323242B1 (en) *	1998-12-02	2001-11-27	Peter Sterling Mueller	Treatment of disorders secondary to organic impairments
CA2366660A1 (en) *	1999-03-19	2000-09-28	Carl M. Mendel	Treatment of osteoarthritis
HUP0200898A3 (en)	1999-04-06	2005-09-28	Sepracor Inc	Derivatives of venlafaxine and methods of preparing and using the same
US6399826B1 (en)	1999-08-11	2002-06-04	Sepracor Inc.	Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US20020115727A1 (en) *	2000-12-04	2002-08-22	Senanayake Chris H.	Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines
EP2319826A1 (en)	2001-02-12	2011-05-11	Wyeth LLC	Succinate salt of O-desmethyl-venlafaxin
WO2002083631A1 (en)	2001-04-13	2002-10-24	Sepracor Inc.	Methods of preparing didesmethylsibutramine and other sibutramine derivatives
US6602911B2 (en)	2001-11-05	2003-08-05	Cypress Bioscience, Inc.	Methods of treating fibromyalgia
CN1662231A (en) *	2002-04-24	2005-08-31	柏树生物科学公司	Prevention and treatment of functional somatic disorders, including stress-related disorders
CN1671368A (en) *	2002-07-24	2005-09-21	柏树生物科学公司	Treatment of depression secondary to pain (DSP)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3008993A1 (en) *	1980-03-08	1981-10-01	Röhm Pharma GmbH, 6100 Darmstadt	PHARMACEUTICAL PREPARATIONS
IE52768B1 (en) *	1981-04-06	1988-02-17	Boots Co Ltd	1-arylcyclobutylalkylamine compounds useful as therapeutic agents
ZA821577B (en) *	1981-04-06	1983-03-30	Boots Co Plc	Therapeutic agents
GB8531071D0 (en) *	1985-12-17	1986-01-29	Boots Co Plc	Therapeutic compound
JP2675573B2 (en) *	1988-03-31	1997-11-12	科研製薬株式会社	Brain function improver
IE61928B1 (en) *	1988-11-29	1994-11-30	Boots Co Plc	Treatment of obesity
US5104899A (en) *	1990-08-13	1992-04-14	Sepracor, Inc.	Methods and compositions for treating depression using optically pure fluoxetine

1993
- 1993-06-22 WO PCT/US1993/005966 patent/WO1994000114A1/en not_active Ceased
- 1993-06-22 EP EP93915448A patent/EP0647134A4/en not_active Withdrawn
- 1993-06-22 CA CA002138998A patent/CA2138998A1/en not_active Abandoned
- 1993-06-22 AU AU45428/93A patent/AU4542893A/en not_active Abandoned
- 1993-06-22 JP JP6502536A patent/JPH08500093A/en active Pending

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9400114A1 *

Also Published As

Publication number	Publication date
CA2138998A1 (en)	1994-01-06
EP0647134A1 (en)	1995-04-12
JPH08500093A (en)	1996-01-09
AU4542893A (en)	1994-01-24
WO1994000114A1 (en)	1994-01-06

Similar Documents

Publication	Publication Date	Title
EP0708639A4 (en)	1997-08-20	METHODS AND COMPOSITIONS FOR TREATING DEPRESSION AND OTHER CONDITIONS WITH OPTICALLY PURE SIBUTRAMINE (+)
FR15C0089I2 (en)	2016-07-01	RECOMBINATION IL-5 ANTAGONISTS USEFUL IN THE TREATMENT OF IL-5 INDUCED DISORDERS
FI933946A7 (en)	1994-03-11	Compounds useful as hypoglycemic agents and in the treatment of Alzheimer's disease
FI962557A7 (en)	1996-08-22	Use of PLA2 inhibitors in the treatment of Alzheimer's disease
TR199600498A2 (en)	1997-03-21	Oral formulations of S (+) - ibuprofen.
MA23166A1 (en)	1994-12-31	METHODS OF USING HESPERETINE FOR SEBUM CONTROL AND THE TREATMENT OF ACNE.
AR241025A1 (en)	1991-04-30	NON-IONIC PERLINE GLOSS DISPERSIONS, CAPABLE OF FLOWING "
EP0778727A4 (en)	1998-05-20	PLANT PROMOTER USED TO DIRECT EXPRESSION OF FOREIGN PROTEINS TO THE PLANT EPIDERMIS
DE69405919D1 (en)	1997-11-06	Compositions for the treatment of keratin fibers
TR26214A (en)	1995-02-15	PREPARATION OF BAVIUM OR STRONSIUM SULFID LAVIGATION WASTE.
EP1007036A4 (en)	2001-02-28	METHODS OF USING BUTYRIC ACID OR BUTYRIC ACID DERIVATIVES TO PREVENT HAIR LOSS
DE69432706D1 (en)	2003-06-26	METHOD FOR CLEANING "BASIC" FIBROBLAST GROWTH FACTOR
DE69519799D1 (en)	2001-02-08	METHOD FOR THE PRODUCTION OF [S, S] -ETHYLENE DIAMINE-N, N'-DIBERONIC ACID
DE69401368D1 (en)	1997-02-20	Process for the preparation of 1,4-dicyano-2-butene
ITBO950012A0 (en)	1995-01-19	LIQUID SUPPLEMENT FOR THE ENRICHMENT OF FERTILIZERS AND FERTILIZERS
FR2757179B1 (en)	1999-01-08	PROCESS FOR THE PREPARATION OF AMIDES OF ACRYLIC OR METHACRYLIC ACID
MD145B1 (en)	1995-01-30	Brendi "botna" drink
NO178763C (en)	1996-05-29	Process for the preparation of racemically and optically active 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and intermediates thereof
DE59401800D1 (en)	1997-03-27	Process for the preparation of 1,1'-binaphthylene
ITTO930806A1 (en)	1994-05-19	PURIFICATION OF 1, 1-DICHLORO-1-FLUOROETHANE.
EP0979234A4 (en)	2002-10-30	METHODS AND COMPOSITIONS APPLICABLE TO THE DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC DISORDERS
EP1052900A4 (en)	2001-07-18	METHODS AND COMPOSITIONS FOR LIMITING THE GROWTH OF MICROORGANISMS USING BROMONITROSTYRENE AND PERACETIC ACID
FR2734838B1 (en)	1997-08-22	FRAGMENT OF NUCLEIC ACID ENCODING AN ENZYME INVOLVED IN THE BIOSYNTHESIS PATHWAY OF ABSCISIC ACID (ABA) IN PLANTS
FR2707313B1 (en)	1999-02-26	Removable and versatile anchoring and connecting structure for pre-infrastructure frames.
CA2217463A1 (en)	1998-04-04	Use of sulbutiamine to obtain pharmaceutical compositions which are useful in the treatment of some psychomotor and psychointellectual disorders

Legal Events

Date	Code	Title	Description
1995-02-24	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1995-04-12	17P	Request for examination filed	Effective date: 19950118
1995-04-12	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
1997-07-30	A4	Supplementary search report drawn up and despatched	Effective date: 19970612
1997-07-30	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
2000-01-05	17Q	First examination report despatched	Effective date: 19991118
2002-12-18	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: SEPRACOR INC.
2005-05-20	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2005-07-06	18D	Application deemed to be withdrawn	Effective date: 20050101